Results 161 to 170 of about 80,923 (291)
Effects of spinal sympathicolysis on gastrointestinal motility in critically ill patients [PDF]
Petra Wegermann, M. Tryba
openalex +1 more source
This manuscript presents a carrier‐free nanomedicine PCNPs@PEG‐Man with dual‐targeting for IBD. It resists harsh intestinal conditions, reduces oxidative stress, enhances drug uptake and retention, modulates inflammation, and reshapes gut microbiota, offering a safe and effective IBD therapy.
Yingjie Chen+8 more
wiley +1 more source
Nutritional Management of Pediatric Gastrointestinal Motility Disorders. [PDF]
Jackman L+4 more
europepmc +1 more source
Diagnostics of Gastrointestinal Motility and Function: Update for Clinicians. [PDF]
Mari A.
europepmc +1 more source
High QSOX2 enhances stemness, drug resistance, and metastasis of ESCC cells. QSOX2‐mediated disulfide bond modification activates mTOR/c‐Myc signaling. CAFs‐secreted IGF‐1 drives mTOR/c‐Myc/QSOX2 positive feedback loop. Combining Ebselen, rapamycin, and cisplatin induces tumor dormancy in mice.
Wo‐Ming Chen+12 more
wiley +1 more source
Differences in Gastrointestinal Motility in Adults with Type 1 and Type 2 Diabetes Using Wireless Motility Capsule. [PDF]
Garg S+8 more
europepmc +1 more source
Progesterone inhibitory role on gastrointestinal motility. [PDF]
Alqudah M+4 more
europepmc +1 more source
Effects of xylazine on gastrointestinal motility in goats and dogs.
Chihaya Kakinuma+3 more
openalex +2 more sources
We demonstrate that Foxp1± mice, modeling FOXP1 haploinsufficiency, exhibit behavioral deficits, striatal neuroinflammatory changes including altered microglial complexity and synaptic pruning, and markedly reduced Pde10a expression. Pde10a inhibition starting immediately after birth restores Foxp1± behavior, microglial morphology, and pruning ...
Henning Fröhlich+8 more
wiley +1 more source